Low-power versus high-power laser for holmium laser enucleation of prostate: systematic review and meta-analysis.

ABSTRACT:

Objective

Holmium laser enucleation of the prostate (HoLEP) has emerged as a minimally invasive alternative to transurethral resection of the prostate (TURP), offering benefits such as reduced bleeding and faster recovery. While high-power (HP, 80-100 W) is widely used, low-power (LP, 20-50 W) has gained attention for its cost-effectiveness and versatility. This study presents the first meta-analysis of randomized controlled trials (RCTs) comparing the outcomes of low-power (LP) and high-power (HP) HoLEPin patients with benign prostatic hyperplasia (BPH).

Methods

RCTs were retrieved from PubMed, Embase, Web of Science, and the Cochrane Library up to February 28, 2025. Primary outcomes included the International Prostate Symptom Score (IPSS) at three months and intraoperative

SUBMITTER: Chen L 

PROVIDER: S-EPMC12006225 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature